MYC and lung cancer: Regarding the downstream mechanisms of PDK2, Sun et al. showed that PDK2 knockdown sensitizes lung cancer cells to paclitaxel via inhibiting c-Myc and HIF-1α expression and suppresses the glucose uptake via downregulating glucose transporter-1 (GLUT1) expression [28].